Pharmacological Actions of Cannabinoids 43Gallily R, Even-Chen T, Katzavian G, Lehmann D, Dagan A, Mechoulam R (2003)γ-
Irradiation enhances apoptosis induced by cannabidiol, a non-psychotropic cannabi-
noid, in cultured HL-60 myeloblastic leukemia cells. Leuk Lymphoma 44:1767–1773
Gareau Y, Dufresne C, Gallant M, Rochette C, Sawyer N, Slipetz DM, Tremblay N, Weech PK,
Metters KM, Labelle M (1996) Structure activity relationships of tetrahydrocannabinol
analogues on human cannabinoid receptors. Bioorg Med Chem Lett 6:189–194
Gatley SJ, Lan R, Volkow ND, Pappas N, King P, Wong CT, Gifford AN, Pyatt B, Dewey SL,
Makriyannis A (1998) Imaging the brain marijuana receptor: development of a radioli-
gand that binds to cannabinoid CB1 receptors in vivo. J Neurochem 70:417–423
Gérard CM, Mollereau C, Vassart G, Parmentier M (1991) Molecular cloning of a human
cannabinoid receptor which is also expressed in testis. Biochem J 279:129–134
Gifford AN, Tang Y, Gatley SJ, Volkow ND, Lan R, Makriyannis A (1997) Effect of the
cannabinoid receptor SPECT agent, AM 281, on hippocampal acetylcholine release
from rat brain slices. Neurosci Lett 238:84–86
Gifford AN, Makriyannis A, Volkow ND, Gatley SJ (2002) In vivo imaging of the brain
cannabinoid receptor. Chem Phys Lipids 121:65–72
Glass M, Felder CC (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2
receptorsaugmentscAMPaccumulationinstriatalneurons:evidenceforaGslinkage
to the CB1 receptor. J Neurosci 17:5327–5333
Godlewski G, Göthert M, Malinowska B (2003) Cannabinoid receptor-independent inhibi-
tion by cannabinoid agonists of the peripheral 5-HT3 receptor-mediated von Bezold-
Jarisch reflex. Br J Pharmacol 138:767–774
Gonsiorek W, Lunn C, Fan X, Narula S, Lundell D, Hipkin RW (2000) Endocannabinoid
2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor:
antagonism by anandamide. Mol Pharmacol 57:1045–1050
Göthert M, Brüss M, Bönisch H, Molderings GJ (1999) Presynaptic imidazoline receptors:
new developments in characterization and classification. Ann N Y Acad Sci 881:171–184
Goutopoulos A, Fan P, Khanolkar AD, Xie X-Q, Lin S, Makriyannis A (2001) Stereochemical
selectivity of methanandamides for the CB1 and CB2 cannabinoid receptors and their
metabolic stability. Bioorg Med Chem 9:1673–1684
Griffin G, Fernando SR, Ross RA, McKay NG, Ashford MLJ, Shire D, Huffman JW, Yu S,
Lainton JAH, Pertwee RG (1997) Evidence for the presence of CB2-like cannabinoid
receptors on peripheral nerve terminals. Eur J Pharmacol 339:53–61
Griffin G, Tao Q, Abood ME (2000) Cloning and pharmacological characterization of the
rat CB2 cannabinoid receptor. J Pharmacol Exp Ther 292:886–894
Hájos N, Freund TF (2002a) Pharmacological separation of cannabinoid sensitive receptors
on hippocampal excitatory and inhibitory fibers. Neuropharmacology 43:503–510
Hájos N, Freund TF (2002b) Distinct cannabinoid sensitive receptors regulate hippocampal
excitation and inhibition. Chem Phys Lipids 121:73–82
Hájos N, Katona I, Naiem SS, Mackie K, Ledent C, Mody I, Freund TF (2000) Cannabinoids
inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci
12:3239–3249
Hájos N, Ledent C, Freund TF (2001) Novel cannabinoid-sensitive receptor mediates in-
hibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience
106:1–4
Hampson AJ, Grimaldi M, Axelrod J, Wink D (1998) Cannabidiol and (–)∆9-tetrahydro-
cannabinol are neuroprotective antioxidants. Proc Natl Acad Sci USA 95:8268–8273
Hampson AJ, Grimaldi M, Lolic M, Wink D, Rosenthal R, Axelrod J (2000) Neuroprotective
antioxidants from marijuana. Ann N Y Acad Sci 899:274–282
HanusL,BreuerA,TchilibonS,ShiloahS,GoldenbergD,HorowitzM,PertweeRG,Ross
RA, Mechoulam R, Fride E (1999) HU-308: a specific agonist for CB2, a peripheral
cannabinoid receptor. Proc Natl Acad Sci USA 96:14228–14233
HanusL,Abu-LafiS,FrideE,BreuerA,VogelZ,ShalevDE,KustanovichI,Mechoulam
R (2001) 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1
receptor. Proc Natl Acad Sci USA 98:3662–3665